Clinical evaluation of atenolol in hypertensive patients.
- 1 August 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 64 (2), 368-374
- https://doi.org/10.1161/01.cir.64.2.368
Abstract
Atenolol, a cardioselective beta-adrenergic blocking agent, was given as the sole hypotensive drug for 8-12 weeks to 20 patients with hypertension of varying degrees of severity. Initial systolic blood pressure ranged from 162-238 mm Hg (mean +/- SEM 196 +/- 5.5 mm Hg) and diastolic blood pressure ranged from 105-143 mm Hg (118 +/- 2.5 mm Hg). Three patients had accelerated hypertension, six had cardiomegaly with recent exertional dyspnea and three were diabetics. Atenolol, 100-300 mg once daily, controlled both the supine and standing blood pressure and markedly attenuated the initial hypertensive response to severe exercise. In 17 patients (85%), atenolol therapy reduced blood pressure more than 20/10 mm Hg; however, adequate blood pressure control was not achieved in severe hypertension. A significant hypotensive action developed within 2 weeks of treatment, and control of hypertension was maintained for 2 weeks after sudden interruption of therapy. No patient had postural or postexercise hypotension. The drug appeared to exert its maximum hypotensive effect at the 100-mg dosage. The magnitude of the hypotensive response was related to the initial systolic blood pressure (r = 0.77, p less than 0.01) and the degree of inhibition of exercise tachycardia (r = 0.66, p less than 0.01). The atenolol plasma level and its hypotensive action were not related. Except for impairment of glucose tolerance in diabetic patients, atenolol had minimal side effects.This publication has 19 references indexed in Scilit:
- A comparison of once and twice daily atenolol in hypertensionPublished by Oxford University Press (OUP) ,1977
- Atenolol, methyldopa, and chlorthalidone in moderate hypertension.BMJ, 1977
- Once-daily dosing with Atenolol in patients with mild or moderate hypertension.BMJ, 1976
- Long‐term Hypotensive Effect of Atenolol (ICI 66.082), a New β‐adrenergic Blocking AgentActa Medica Scandinavica, 1976
- Atenolol and bendrofluazide in hypertension.BMJ, 1975
- The gas chromatographic determination of atenolol in biological samplesJournal of Pharmacy and Pharmacology, 1975
- A comparison of timolol and propranolol in essential hypertensionAmerican Heart Journal, 1975
- Management of severe hypertensionThe American Journal of Cardiology, 1973
- Treatment of Hypertension with PropranololBMJ, 1969
- The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leadsAmerican Heart Journal, 1949